US 8859585
Scopolamine for the treatment of depression and anxiety
granted A61KA61K31/46A61K45/06
Quick answer
US patent 8859585 (Scopolamine for the treatment of depression and anxiety) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Oct 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/46, A61K45/06, A61K9/0073, A61P